Soomro, A.; Trink, J.; O’Neil, K.; Li, R.; Naiel, S.; Gao, B.; Ask, K.; Krepinsky, J.C.
Activin A and Cell-Surface GRP78 Are Novel Targetable RhoA Activators for Diabetic Kidney Disease. Int. J. Mol. Sci. 2021, 22, 2839.
https://doi.org/10.3390/ijms22062839
AMA Style
Soomro A, Trink J, O’Neil K, Li R, Naiel S, Gao B, Ask K, Krepinsky JC.
Activin A and Cell-Surface GRP78 Are Novel Targetable RhoA Activators for Diabetic Kidney Disease. International Journal of Molecular Sciences. 2021; 22(6):2839.
https://doi.org/10.3390/ijms22062839
Chicago/Turabian Style
Soomro, Asfia, Jackie Trink, Kian O’Neil, Renzhong Li, Safaa Naiel, Bo Gao, Kjetil Ask, and Joan C. Krepinsky.
2021. "Activin A and Cell-Surface GRP78 Are Novel Targetable RhoA Activators for Diabetic Kidney Disease" International Journal of Molecular Sciences 22, no. 6: 2839.
https://doi.org/10.3390/ijms22062839
APA Style
Soomro, A., Trink, J., O’Neil, K., Li, R., Naiel, S., Gao, B., Ask, K., & Krepinsky, J. C.
(2021). Activin A and Cell-Surface GRP78 Are Novel Targetable RhoA Activators for Diabetic Kidney Disease. International Journal of Molecular Sciences, 22(6), 2839.
https://doi.org/10.3390/ijms22062839